Ten-Year Outcomes of PRE-COMBAT Trial

Conditions

Coronary Artery Disease

Keywords

PCI, CABG, Left main

Brief summary

This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).

Detailed description

This study is an extended one of PRECOMBAT trial.

Tae‐Sun Kim, Do‐Yoon Kang, Sehee Kim, Jeen Hwa Lee, Ah‐Ram Kim et al. (14 authors)

JACC Asia2023-01-254 citations

10.1016/j.jacasi.2022.10.007

Prognostic Value of Sex After Revascularization for Left Main Coronary Disease

Yujin Yang, Yeong Jin Jeong, Junho Hyun, Junghoon Lee, Ju Hyeon Kim et al. (11 authors)

JACC Asia2021-11-098 citations

10.1016/j.jacasi.2021.08.009

Ten‐year Outcomes After Drug‐Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow‐Up Study

Yeong Jin Jeong, Jung‐Min Ahn, Junho Hyun, Junghoon Lee, Ju Hyeon Kim et al. (17 authors)

Journal of the American Heart Association2021-07-0923 citations

10.1161/jaha.120.019834

Prognostic Effect of the SYNTAX Score on 10‐Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial

Junghoon Lee, Jung‐Min Ahn, Ju Hyeon Kim, Yeong Jin Jeong, Junho Hyun et al. (13 authors)

Journal of the American Heart Association2021-07-0613 citations

10.1161/jaha.120.020359

Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease

Duk‐Woo Park, Jung‐Min Ahn, Kwang‐Hyub Han, Sung‐Cheol Yun, Do‐Yoon Kang et al. (19 authors)

Circulation2020-03-30181 citations

10.1161/circulationaha.120.046039

Interventions

PROCEDUREPercutaneous coronary intervention

Using sirolimus eluting stent

PROCEDUREcoronary artery bypass graft

coronary artery bypass graft

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Subject group enrolled in PRECOMBAT trial

Design outcomes

Primary

Measure	Time frame	Description
Composite outcome	10 year	The composite of death, myocardial infarction, and revascularization. Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, and revascularization

Secondary

Measure	Time frame
Cardiac death	10 year
Myocardial infarction	10 year
Cerebrovascular accident	10 year
Target vessel revascularization	10 year
All-cause mortality	10 year
Stent thrombosis	10 year
Binary restenosis in both in-stent and in-segment	10 year
Graft reocclusion rate	10 year
Graft patency rate	10 year
Target lesion revascularization	10 year

Countries

South Korea

Outcome results

None listed